DEL PAPA, BEATRICE
 Distribuzione geografica
Continente #
NA - Nord America 2.107
EU - Europa 1.619
AS - Asia 1.437
SA - Sud America 231
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.443
Nazione #
US - Stati Uniti d'America 2.064
SG - Singapore 650
IT - Italia 379
IE - Irlanda 292
CN - Cina 263
BR - Brasile 178
DE - Germania 176
HK - Hong Kong 159
RU - Federazione Russa 154
VN - Vietnam 146
FI - Finlandia 110
SE - Svezia 105
UA - Ucraina 101
FR - Francia 84
GB - Regno Unito 73
KR - Corea 52
IN - India 46
RO - Romania 40
TR - Turchia 24
BD - Bangladesh 23
BE - Belgio 22
MX - Messico 20
CA - Canada 19
CZ - Repubblica Ceca 18
AR - Argentina 15
AT - Austria 14
PL - Polonia 13
UZ - Uzbekistan 13
EC - Ecuador 12
CO - Colombia 9
JP - Giappone 9
MA - Marocco 9
ES - Italia 8
ET - Etiopia 8
IQ - Iraq 8
LT - Lituania 7
PH - Filippine 7
PK - Pakistan 7
ZA - Sudafrica 7
CH - Svizzera 6
VE - Venezuela 6
CI - Costa d'Avorio 5
EG - Egitto 5
NL - Olanda 5
CL - Cile 4
KE - Kenya 4
AZ - Azerbaigian 3
GR - Grecia 3
ID - Indonesia 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
BG - Bulgaria 2
BO - Bolivia 2
KZ - Kazakistan 2
PT - Portogallo 2
QA - Qatar 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MM - Myanmar 1
OM - Oman 1
PY - Paraguay 1
RE - Reunion 1
SC - Seychelles 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
YT - Mayotte 1
Totale 5.443
Città #
Singapore 484
Chandler 294
Dublin 292
San Jose 197
San Mateo 193
Perugia 188
Hong Kong 159
Ashburn 128
Boardman 80
Beijing 72
Ann Arbor 70
Santa Clara 69
Munich 66
Jacksonville 55
Seoul 52
Dong Ket 51
Altamura 48
Lauterbourg 47
Medford 46
Princeton 45
New York 44
Moscow 43
Helsinki 41
Bucharest 40
Los Angeles 39
Andover 38
Turku 37
Wilmington 36
Lawrence 35
Foligno 33
Ho Chi Minh City 29
Brussels 22
Council Bluffs 21
Dearborn 21
Hanoi 21
Redwood City 19
São Paulo 19
Piscataway 16
The Dalles 16
Dallas 13
Des Moines 13
Houston 13
London 13
Brno 12
Norwalk 12
Assisi 11
Izmir 11
Brooklyn 10
Woodbridge 10
Frankfurt am Main 9
Rio de Janeiro 9
Shanghai 9
Tokyo 9
Vienna 9
Barnet 8
Falls Church 8
Saint Petersburg 8
San Paolo di Civitate 8
Warsaw 8
Addis Ababa 7
Belo Horizonte 7
Hefei 7
Mexico City 7
Quito 7
San Francisco 7
Stockholm 7
Tashkent 7
Boston 6
Chennai 6
Chicago 6
Da Nang 6
Denver 6
Falkenstein 6
Mumbai 6
Orem 6
Toronto 6
Abidjan 5
Ankara 5
Atlanta 5
Guangzhou 5
Rome 5
Bastia 4
Caracas 4
Casablanca 4
Changsha 4
Charlotte 4
Madrid 4
Nuremberg 4
Ottawa 4
Redmond 4
Amsterdam 3
Aurora 3
Baghdad 3
Biên Hòa 3
Bologna 3
Buenos Aires 3
Cairo 3
Collazzone 3
Columbus 3
Johannesburg 3
Totale 3.610
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 179
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 176
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 168
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 154
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 150
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 143
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 134
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 130
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 129
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 129
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 126
Mesenchymal cells: a vehicle for gene therapy 123
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 119
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 119
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 119
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 118
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 116
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 115
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 115
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 114
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 109
T regulatory cell separation for clinical application. 109
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 108
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 107
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 106
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 105
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 105
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 105
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 104
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 102
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 99
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 99
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 96
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 95
Exploring the radiosensitizing potential of AZD8931: a pilot study on the human LoVo colorectal cancer cell line 93
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 91
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 89
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 88
New mechanism of lymphoma-induced bone marrow aplasia 86
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production. 85
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 83
Interleukin 7-engineered stromal cells: a new approach for hastening naive T cell recruitment 83
Mesenchymal cells recruit and regulate T regulatory cells. 83
Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. 83
IL-7 engineered donor stromal cells in vitro: a new approach for hastening naive T cell recruitment. 79
Catalase prevents DNA damage and cationic current activation by silver nanoparticles in U251 human glioblastoma cell line 77
A DYSREGULATED, DRUGGABLE PP2A/AKT/GSK3 beta AXIS SUSTAINS NOTCH1 SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 75
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 72
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 70
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 67
NOTCH and Graft-Versus-Host Disease 64
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 62
null 37
Totale 5.592
Categoria #
all - tutte 23.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.379


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 14 31 59
2021/2022605 12 174 8 21 14 6 9 124 4 55 81 97
2022/2023910 48 169 8 82 75 83 0 45 346 1 35 18
2023/2024441 19 44 27 23 2 17 137 6 16 20 57 73
2024/2025826 41 82 19 43 93 29 44 55 148 43 133 96
2025/20261.799 123 122 85 198 288 201 321 92 198 171 0 0
Totale 5.592